These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28441902)

  • 21. Acute Radiation Effects, the H-ARS in the Non-human Primate: A Review and New Data for the Cynomolgus Macaque with Reference to the Rhesus Macaque.
    Farese AM; Drouet M; Herodin F; Bertho JM; Thrall KD; Authier S; Doyle-Eisele M; MacVittie TJ
    Health Phys; 2021 Oct; 121(4):304-330. PubMed ID: 34546214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing.
    MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W
    Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for use.
    Singh VK; Hanlon BK; Santiago PT; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):885-906. PubMed ID: 28657400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat Models of Partial-body Irradiation with Bone Marrow-sparing (Leg-out PBI) Designed for FDA Approval of Countermeasures for Mitigation of Acute and Delayed Injuries by Radiation.
    Fish BL; MacVittie TJ; Gao F; Narayanan J; Gasperetti T; Scholler D; Sheinin Y; Himburg HA; Hart B; Medhora M
    Health Phys; 2021 Oct; 121(4):419-433. PubMed ID: 34546222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WAG/RijCmcr rat models for injuries to multiple organs by single high dose ionizing radiation: similarities to nonhuman primates (NHP).
    Fish BL; MacVittie TJ; Szabo A; Moulder JE; Medhora M
    Int J Radiat Biol; 2020 Jan; 96(1):81-92. PubMed ID: 30575429
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute radiation syndrome drug discovery using organ-on-chip platforms.
    Singh VK; Seed TM
    Expert Opin Drug Discov; 2022 Aug; 17(8):865-878. PubMed ID: 35838021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of biomarkers for assessing radiation injury and efficacy of countermeasures.
    Singh VK; Newman VL; Romaine PL; Hauer-Jensen M; Pollard HB
    Expert Rev Mol Diagn; 2016; 16(1):65-81. PubMed ID: 26568096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosensitivity of rhesus nonhuman primates: consideration of sex, supportive care, body weight, and age at time of exposure.
    Singh VK; Carpenter AD; Janocha BL; Petrus SA; Fatanmi OO; Wise SY; Seed TM
    Expert Opin Drug Discov; 2023 Jul; 18(7):797-814. PubMed ID: 37073409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opportunities and challenges with animal models for acute radiation syndrome drug discovery.
    Singh VK; Santiago PT; MacVittie TJ
    Expert Opin Drug Discov; 2018 Nov; 13(11):987-992. PubMed ID: 30269616
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.
    Singh VK; Romaine PL; Seed TM
    Health Phys; 2015 Jun; 108(6):607-30. PubMed ID: 25905522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents.
    Singh VK; Garcia M; Wise SY; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1431-1447. PubMed ID: 27599259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
    Shurtleff AC; Bavari S
    Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures.
    Singh VK; Beattie LA; Seed TM
    J Radiat Res; 2013 Nov; 54(6):973-88. PubMed ID: 23658414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The delayed effects of acute radiation exposure (DEARE): characteristics, mechanisms, animal models, and promising medical countermeasures.
    Wu T; Orschell CM
    Int J Radiat Biol; 2023; 99(7):1066-1079. PubMed ID: 36862990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates.
    Hankey KG; Farese AM; Blaauw EC; Gibbs AM; Smith CP; Katz BP; Tong Y; Prado KL; MacVittie TJ
    Radiat Res; 2015 Jun; 183(6):643-55. PubMed ID: 26035709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed effects of radiation exposure in a C57L/J mouse model of partial body irradiation with ~2.5% bone marrow shielding.
    Beach T; Bakke J; McDonald JT; Riccio E; Javitz HS; Nishita D; Kapur S; Bunin DI; Chang PY
    Front Public Health; 2024; 12():1349552. PubMed ID: 38544733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Overview of Radiation Countermeasure Development in Radiation Research from 1954 to 2024.
    Kiang JG; Cannon G; Singh VK
    Radiat Res; 2024 Aug; 202(2):420-431. PubMed ID: 38964743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total body irradiation models in NHPs - consideration of animal sex and provision of supportive care to advance model development.
    Beach T; Authier S; Javitz HS; Wong K; Bakke J; Gahagen J; Bunin DI; Chang PY
    Int J Radiat Biol; 2021; 97(2):126-130. PubMed ID: 33259246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARS, DEARE, and Multiple-organ Injury: A Strategic and Tactical Approach to Link Radiation Effects, Animal Models, Medical Countermeasures, and Biomarker Development to Predict Clinical Outcome.
    MacVittie TJ; Farese AM; Kane MA
    Health Phys; 2019 Mar; 116(3):297-304. PubMed ID: 30608246
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of a partial-body irradiation model with oral cavity shielding in nonhuman primates.
    Accardi MV; Donini O; Rumage A; Ascah A; Haruna J; Pouliot M; Bujold K; Huang H; Wierzbicki W; Stamatopoulos J; Naraghi H; Measey T; Authier S
    Int J Radiat Biol; 2020 Jan; 96(1):100-111. PubMed ID: 29447591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.